Skip to content

Does a pain management programme impact on patients quality of sleep?

Cognitive behavioural pain management programmes: impact on sleep quality in patients with chronic pain

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN74913595
Enrollment
50
Registered
2010-09-13
Start date
2009-02-02
Completion date
Unknown
Last updated
2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic non-malignant pain Signs and Symptoms Pain

Interventions

Cognitive Behavioural Pain Management Programme (CBT-PMP): A multi-disciplinary CBT-PMP provides the patient with multiple therapies involving comprehensive rehabilitation in each of t
the intervention group were re-assessed on completion of the 4-week pain management programme and again 2 months later. The waiting list control group were reassessed a

Sponsors

Pfizer Healthcare Ireland (PHI) (Ireland)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients aged over 18 years, either sex 2. Patients with a diagnosis of chronic pain (pain greater than 6 months) 3. Patients who fulfil the criteria for the Adelaide and Meath Hospitals incorporating the National Children's Hospital (AMNCH) cognitive behavioural pain management programme (CBT-PMP) as per the multidisciplinary team 4. Patients willing to take part in the study 5. Patients who are suffering from sleep disturbance due to pain as determined by the Pittsburgh Sleep Quality Index questionnaire (a score greater than 5 indicating sleep disturbance)

Exclusion criteria

Exclusion criteria: 1. Patients under 18 years 2. Patients who do not have a diagnosis of pain greater than 6 months duration 3. Deemed unsuitable for the AMNCH CBT-PMP as per the multidisciplinary pain team 4. Unwilling to take part in the study 5. Do not suffer from sleep disturbance due to pain as determined by the Pittsburgh Sleep Quality Index questionnaire (a score greater than 5 indicating sleep disturbance) 6. Pregnancy

Design outcomes

Primary

MeasureTime frame
Patients and controls will be assessed one week prior to the commencement of the CBT-PMP, 4 weeks later on completion of the CBT-PMP (or usual care), and two months later: 1. Sleep: 1.1. Objective: Patients will be instructed to wear the Actiwatch (AW4, CamTech, Cambridge, UK) for 7 days (24 hours a day) 1.2. Self-report: Pittsburgh Sleep diary (PghSD) for 7 days 2. Physical Function (objective): The Simmond's functional assessment battery of tests 3. Pain (self-report): Numerical rating scale for current pain, pain at worst/best in last 7 days 4. Psychosocial beliefs (self-report): Tampa Scale of Kinesophobia (fear of re-injury), Hospital Anxiety and Depression Questionnaire 5. Health-related Quality of Life and function (self-report): 36-item short form health survey (SF-36)

Secondary

MeasureTime frame
No secondary outcome measures

Countries

Ireland

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 29, 2026